News8 months ago
Calidi Biotherapeutics Reports First Quarter 2024 Operating and Financial Results
Three upcoming posters, including an update on the ongoing Phase 1 trial of Calidi’s CLD-101 program, to be presented at the 2024 ASCO Annual Meeting Presented...